RYBODYN ANNOUNCES SEED FINANCING TO ADVANCE AI-DRIVEN DISCOVERY OF HIDDEN CANCER TARGETS

Company's CypherAtlas™ database emerges as one of oncology's largest integrated dark transcriptome and proteome resources SAN DIEGO, March 24, 2026 /PRNewswire/ -- RyboDyn, Inc., a biotechnology company decoding the dark proteome using an AI-powered novel sequencing and discovery...

Read More